Correlation Between Pasithea Therapeutics and Acumen Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Acumen Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Acumen Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Acumen Pharmaceuticals, you can compare the effects of market volatilities on Pasithea Therapeutics and Acumen Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Acumen Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Acumen Pharmaceuticals.
Diversification Opportunities for Pasithea Therapeutics and Acumen Pharmaceuticals
0.89 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Pasithea and Acumen is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Acumen Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acumen Pharmaceuticals and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Acumen Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acumen Pharmaceuticals has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Acumen Pharmaceuticals go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Acumen Pharmaceuticals
Given the investment horizon of 90 days Pasithea Therapeutics Corp is expected to under-perform the Acumen Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Pasithea Therapeutics Corp is 1.11 times less risky than Acumen Pharmaceuticals. The stock trades about -0.45 of its potential returns per unit of risk. The Acumen Pharmaceuticals is currently generating about -0.25 of returns per unit of risk over similar time horizon. If you would invest 185.00 in Acumen Pharmaceuticals on November 5, 2024 and sell it today you would lose (35.00) from holding Acumen Pharmaceuticals or give up 18.92% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
Pasithea Therapeutics Corp vs. Acumen Pharmaceuticals
Performance |
Timeline |
Pasithea Therapeutics |
Acumen Pharmaceuticals |
Pasithea Therapeutics and Acumen Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pasithea Therapeutics and Acumen Pharmaceuticals
The main advantage of trading using opposite Pasithea Therapeutics and Acumen Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Acumen Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will offset losses from the drop in Acumen Pharmaceuticals' long position.Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Virax Biolabs Group | Pasithea Therapeutics vs. Revelation Biosciences |
Acumen Pharmaceuticals vs. CytomX Therapeutics | Acumen Pharmaceuticals vs. Instil Bio | Acumen Pharmaceuticals vs. Spero Therapeutics | Acumen Pharmaceuticals vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |